Home > Education > Past Courses & Webinars > ESSO – SBCO joint webinar on The Role of ctDNA in Patients With Peritoneal Metastases From Colorectal Cancer & CRS/HIPEC
ESSO – SBCO joint webinar on The Role of ctDNA in Patients With Peritoneal Metastases From Colorectal Cancer & CRS/HIPEC
Aim of the webinar
This ESSO-SBCO collaborative webinar will explore the emerging role of circulating tumor DNA (ctDNA) in the management of peritoneal metastases from colorectal cancer, particularly in the selection of patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Expert faculty from Europe, North America, and Latin America will share the latest evidence on ctDNA as a prognostic and predictive biomarker, its implications for recurrence monitoring, and its potential to refine patient selection strategies.
Speakers
Niels Kok
Netherlands Cancer Institute, Amsterdam, NL
Kiran Turaga
Yale School of Medicine, New Haven, US
Frederico Teixeira
Hospital Israelita Albert Einstein, Sao Paulo, BR
Moderators
Eduardo Akaishi
University of Sao Paulo Medical School, Sao Paulo, BR
Diane Goere
Saint-Louis Hospital, Paris, FR
Artur Reis
Centro de Oncologia do Peritônio, Sao Paulo, BR
Key topics
Webinar video
Other webinars you may be interested in